Showing 641-650 of 6963 results for "".
"Psleep": Psoriasis and Sleep
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/psleep-psoriasis-and-sleep/29075/The “invisible” impacts of psoriasis are those not directly seen on examination. These include itch, pain, fatigue and sleep dysfunction, which may be improved by our systemic therapies. However, there is a gap between the patients’ reporting of these experienced invisible impacts and their physiciaAesthetic Dermatology in 2021
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-dermatology-in-2021/23468/A look at how the COVID-19 pandemic has affected the demand for aesthetic procedures in dermatology offices around the country.The Skin After Cancer
https://practicaldermatology.com/topics/general-topics/the-skin-after-cancer/20797/There are lots of questions, but still few answers. Here's what we know.Inside Cosmeceutical Marketing Claims
https://practicaldermatology.com/topics/general-topics/inside-cosmeceutical-marketing-claims/21642/Dermatologists and their patients may wonder what makes a product “dermatologist tested” or “clinically proven.” Here's what you need to know.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Rediscovering Topical Antifungal Therapy for Onychomycosis
https://practicaldermatology.com/topics/hair-nails/rediscovering-topical-antifungal-therapy-for-onychomycosis/22974/A number of potential topical therapies for onychomycosis have failed clinical investigation. Do we at last have a viable alternative to oral treatment options?Newly Approved Therapies for the Treatment of Plaque Psoriasis in Adults
https://practicaldermatology.com/topics/psoriasis/newly-approved-therapies-for-the-treatment-of-plaque-psoriasis-in-adults/23213/Here’s a closer a look at recently approved agents.Microbiome in Practice: Assessing OTC Options
https://practicaldermatology.com/topics/atopic-dermatitis/microbiome-in-practice-assessing-otc-options/23123/There’s still much to learn, but clinicians already have tools to manipulate the microbiome.Are We Overlooking Skin Cancer in Ethnic Minorities?
https://practicaldermatology.com/issues/supplements/are-we-overlooking-skin-cancer-in-ethnic-minorities/21718/Skin cancers in Hispanic and African American patients may be detected at more advanced stages, leading to poorer prognoses and long-term outcomes compared to non-Hispanic whites.Monitoring Biologic Therapy In Psoriasis: A Primer
https://practicaldermatology.com/topics/psoriasis/monitoring-biologic-therapy-in-psoriasis-a-primer/20931/Treatments are generally safe and well-tolerated, however, prescribers must monitor for risk factors.